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Abstract
Background: Knowledge brokering is a knowledge translation approach that has been gaining popularity in
Canada although the effectiveness is unknown. This study evaluated the effectiveness of generalised, exclusively
email-based prompts versus a personalised remote knowledge broker for delivering evidence-based mood
management interventions within an existing smoking cessation programme in primary care settings.
Methods: The study design is a cluster randomised controlled trial of 123 Ontario Family Health Teams
participating in the Smoking Treatment for Ontario Patients programme. They were randomly allocated 1:1 for
healthcare providers to receive either: a remote knowledge broker offering tailored support via phone and email
(group A), or a generalised monthly email focused on tobacco and depression treatment (group B), to encourage
the implementation of an evidence-based mood management intervention to smokers presenting depressive
symptoms. The primary outcome was participants’ acceptance of a self-help mood management resource. The
secondary outcome was smoking abstinence at 6-month follow-up, measured by self-report of smoking abstinence
for at least 7 previous days. The tertiary outcome was the costs of delivering each intervention arm, which, together
with the effectiveness outcomes, were used to undertake a cost minimisation analysis.
(Continued on next page)
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: peter.selby@camh.ca
1Nicotine Dependence Service, Centre for Addiction and Mental Health, 1025
Queen St W, Toronto, ON M6J 1H4, Canada
2Department of Family and Community Medicine, University of Toronto, 500
University Ave, Toronto, ON M5G 1V7, Canada
Full list of author information is available at the end of the article
Minian et al. Implementation Science           (2021) 16:30 
https://doi.org/10.1186/s13012-021-01091-6
(Continued from previous page)
Results: Between February 2018 and January 2019, 7175 smokers were screened for depression and 2765 (39%)
reported current/past depression. Among those who reported current/past depression, 29% (437/1486) and 27%
(345/1277) of patients accepted the mood management resource in group A and group B, respectively. The
adjusted generalised estimating equations showed that there was no significant difference between the two
treatment groups in patients’ odds of accepting the mood management resource or in the patients’ odds of
smoking abstinence at follow-up. The cost minimisation analysis showed that the email strategy was the least
costly option.
Conclusions: Most participants did not accept the resource regardless of remote knowledge broker strategy. In
contexts with an existing KT infrastructure, decision-makers should consider an email strategy when making
changes to a programme given its lower cost compared with other strategies. More research is required to improve
remote knowledge broker strategies.
Trial registration: ClinicalTrials.gov, NCT03130998. Registered April 18, 2017, (Archived on WebCite at www.
webcitation.org/6ylyS6RTe)
Keywords: Remote knowledge broker, Smoking cessation, Mood management intervention, Knowledge translation
strategies
Contribution to the literature
 Implementation of remote knowledge brokers (rKB) to
support integration of evidence-based treatment in primary
care continues to grow, despite lack of evidence on how ef-
ficacious rKBs are. This study failed to demonstrate the su-
periority of a personalised rKB over generic emails. This is
particularly relevant in the current situation of remote care
provision and complete cessation of in-person KB activities
due to the COVID-19 pandemic.
 This study provides decision-makers with relevant informa-
tion to decide whether to use a rKB in systems with strong
KT infrastructures including virtual components.
 Outcomes of this study also provide information related to
the costs of KT strategies in general, something that is
usually lacking in the published literature.
Background
There is an increased call to use evidence-based prac-
tices (EBP) in the management and delivery of primary
care [1, 2]. While funding agencies and policy- and
decision-makers have promoted the application of EBP
within primary care settings to enhance the quality of
healthcare programmes and improve patient care, imple-
menting new research into clinical practice, and sustain-
ing these evidence-based interventions long term, is
often challenging [3–5]. Various knowledge translation
(KT) strategies have been used to help build capacity
and encourage the implementation of EBP within health-
care settings, including training [6, 7], technology-
enabled supports [8–10], financial incentives [5, 11], pol-
icy initiatives [5] and knowledge brokering [5, 12]. In
Canada, the use of a knowledge broker (KB) is a com-
mon approach to bridge the gap between researchers
and decision-makers [13, 14]. However, while KBs are
well established within the private sector [1, 15, 16], evi-
dence on their role and efficacy within healthcare set-
tings has been largely anecdotal, and often inconclusive
[12, 15, 17–20]. Given the costs and resources associated
with traditional, in-person, models of knowledge broker-
ing [20, 21], some programme implementers have shifted
to remote KB (rKB) services, including virtual communi-
ties of practice (CoP), emails and phone calls [20, 22,
23]. However, the effectiveness of KBs operating from
remote contexts has not been rigorously evaluated in
primary care.
We conducted a cluster randomised controlled trial
(RCT) to examine the effectiveness of two KT strategies
in team-based multidisciplinary primary care settings
(known as Family Health Teams [FHTs]) across Ontario,
Canada, to increase healthcare provider (HCP) capacity
in implementing an evidence-based mood management
intervention within their existing smoking cessation
programme. The intervention was operationalised
through the Smoking Treatment for Ontario Patients
(STOP) programme [24], an existing, in-person, smoking
cessation treatment programme that partners with
clinics across the province to provide up to 26 weeks of
free nicotine replacement therapy (NRT) and behav-
ioural counselling to treatment-seeking tobacco users.
We chose this intervention as there is strong evidence
demonstrating that integrating a psychosocial mood
management component within smoking cessation pro-
gramming can increase long-term quit rates among
smokers with both current and past depression [25].
However, smokers with co-occurring depression are less
likely to be treated for their tobacco use, often due to
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misconceptions regarding treatment approach and efficacy
[26]. Thus, there was a need to develop an intervention to
encourage HCPs to integrate mood interventions within
their smoking cessation practice [26, 27]. Data from the
STOP programme showed that 38% of FHT patients had
current depression (determined by a score of 5 or higher
on the Patient Health Questionnaire-9) or self-reported
past depression, and these participants had significantly
lower 6-month quit rates compared with patients without
depression (33% vs. 40%, p < 0.001) [28]. This is consistent
with the literature [25, 29, 30] which in addition shows
that compared with the general population, individuals
with depression are almost twice as likely to be smokers
[31] and experience greater nicotine dependence, negative
mood changes and higher rates of relapse when making a
quit attempt [25, 29, 30].
The overall aim of this cluster randomised controlled
trial (RCT) was to test a mid-range theory (a theory
whose application is restricted to a certain subset of so-
cial phenomena relevant to a particular range of con-
texts [32]), where we hypothesised that a more intense
and personalised intervention (rKB) would be more ef-
fective at enabling HCPs to provide their patients with
mood management resources when needed, and ultim-
ately help more smokers quit smoking, compared with a
more passive intervention (generic monthly emails).
In this manuscript, we report on the three objectives
set out in our trial protocol [33]:
1. To test the hypothesis that a personalised rKB
(group A) would increase patients’ acceptance of a
mood management resource relative to an active
control condition of generalised email-based
prompts (group B).
2. To test whether the personalised rKB also increased
participants’ smoking quit rates at 6-month follow-
up relative to the general email prompts.
3. To quantify the costs and benefits of the rKB
(group A) relative to the general email prompts
(group B).
A cluster RCT, with FHT clinics as the units of ran-
domisation and STOP programme patients as the unit
of analysis, was chosen to prevent contamination that
would result if providers working within a clinic were
exposed to both arms of the trial.
Methods
To allow for replication of our study interventions, this
trial adheres to reporting standards using the template
for intervention description and replication (TIDieR)
guide [34] and the CONSORT guidelines for cluster
RCTs [35]. The completed TIDieR checklist is included
as Additional File 1. The completed CONSORT
checklist [35] for cluster RCTs is included as Additional
File 2. The study methods described here are described
in more detail in our protocol manuscript [33].
Study design and setting
We conducted a pragmatic cluster RCT in FHTs (clus-
ters) in Ontario implementing the STOP programme.
FHTs joining the STOP programme were required to
sign an Inter-Institutional Clinical Trial Collaborative
Agreement, by which they consent to participate in the
STOP study and conduct all STOP programme proto-
cols in accordance with the agreement. In addition,
HCPs delivering the STOP programme must receive
training from a recognised education programme. Previ-
ous findings show that the majority of FHT HCPs imple-
menting the STOP programme have attended training in
an intensive tobacco cessation counselling programme,
the Training Enhancement in Applied Counselling and
Health (TEACH) Core course [36], while others identi-
fied being trained in less intensive programmes, includ-
ing the Ottawa Model for Smoking Cessation [37], the
Best Practice Champions [38] and the Quit Using and
Inhaling Tobacco (QUIT) programme [24, 39]. The
most common professional designations of HCPs imple-
menting the STOP programme in FHTs are registered
nurse (47.8%), pharmacist (19%) and nurse practitioner
(12%). Other disciplines reported by STOP programme
implementers include registered practical nurse, respira-
tory educator, social worker, addiction/mental health
counsellors and health promoters.
As part of their role, HCPs are required to administer
an initial baseline survey to treatment-seeking tobacco
users who are interested in enrolling in the STOP
programme. This survey includes questions about the
patient’s current tobacco use, general health and socio-
demographic information. HCPs are also responsible for
providing patients with behavioural counselling and dis-
pensing NRT during intake and at scheduled follow-up
appointments. Additional resources and referrals to
other FHT members can also be offered to patients
based on any comorbid conditions and health behav-
iours reported.
Implementation framework
This study was guided by the Interactive Systems Frame-
work (ISF) for Dissemination and Implementation [40].
ISF outlines three interactive systems to implement
scientific knowledge: the synthesis and translation
system (“which distills information about innovations
and translates it into user-friendly formats” [40]), the
support system (“which provides training, technical
assistance or other support to users in the field” [40])
and the delivery system (“which implements innovations
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in the world of practice” [40]). Each of these systems is
described below.
Pre-implementation
Prior to the launch of this trial, we examined the imple-
mentation climate of FHTs using a survey distributed to
125 STOP lead implementer(s) working in FHTs. The
survey captured the three components of organisational
readiness described by Scaccia et al [22]: motivation,
general capacity and innovation-specific capacity. Motiv-
ation was defined as HCPs’ perceptions that the mood
management intervention was compatible with the clinic
values, was needed and would be useful to their patients.
General Capacity was defined as the infrastructure, cul-
ture and context within the organisation in which the
mood management intervention was going to be intro-
duced. General capacities are associated with the ability
to implement any innovation [41]. Innovation-Specific
Capacity was defined as perceived knowledge, skills and
abilities of HCPs to implement a mood management
intervention. Based on answers to this survey, FHTs
were grouped into two categories: most ready, and least
ready. Given that completing the readiness survey was
not a prerequisite to being randomised into the study,
FHTs that did not complete the survey were classified
together in a group labeled “unknown readiness”. For
this trial, FHTs in Ontario, Canada, implementing the
STOP programme, were the delivery system as outlined
in the ISF.
After analysing the readiness survey, we invited FHTs
to participate in two 60-min-long interactive webinars
sharing best practices for integrating mood interventions
into smoking cessation programming. These webinars
formed the basis for the support system outlined in the
ISF. Detailed answers from the readiness survey were
used to develop the content of webinars which were de-
livered by the PI (PS). The recordings of these webinars
can be accessed here: webinar 1: https://tinyurl.com/
y9qhbee5, webinar 2: https://tinyurl.com/y8gmsfsb. The
slide-decks of these webinars were part of the synthesis
system outlined in the ISF.
Trial design
FHTs (i.e. study clusters) were stratified by three levels
of organisational readiness to implement a mood
management intervention, and two levels of clinic size
(estimated annual eligible patient enrollment), resulting
in six strata. Within each of the six strata, a study co-
investigator (DB) randomised clinics using a 1:1 alloca-
tion ratio to either group A (tailored rKB) or group B
(monthly email prompts). The random assignment of
treatment to FHT was computer generated using the
ralloc command in Stata 14. All stratification and group
allocation were performed prior to the initiation of the
study. Participating FHTs were not informed of their al-
location until the trial began. All authors, except SA
who was the rKB and AI, SV and DB who conducted the
analysis, remained blinded until the last follow-up survey
was completed; AI, SV and DB were blinded until
analysis of the primary outcome. Two study staff were
un-blinded to allocation results so as to facilitate imple-
mentation of the random allocation sequence within the
rKB or email groups. Additional details about determin-
ation of the readiness and size strata as well as the




Ontario FHTs who were implementing the STOP
programme at the time of randomisation in February
2018, and used the STOP portal for programme
operations, including patient enrollment, were eligible to
participate in the trial.
Patient level
Patients who provided consent to participate in the
STOP programme, and enrolled in person at an eligible
FHT with their baseline enrollment survey completed in
English by a HCP, using the STOP portal in real-time,
were eligible to participate in the study. Patients who
completed their baseline enrollment on paper, or in
French, were excluded from the trial. In order to be
eligible to receive the mood management intervention at
the time of enrollment, patients must either have re-
ported a past diagnosis of depression or have scored 5
or higher on the Patient Health Questionnaire (PHQ-9)
a validated and widely-used screen for major depressive
disorder, which was already part of the baseline




Based on their PHQ-9 score, which was automatically
calculated by the online portal prior to survey comple-
tion, patients were grouped into one of four possible
levels of depression severity: (1) minimal depressive
symptoms (PHQ-9 score < 4 and a reported history of
depression, or PHQ-9 score 5-9); (2) major depression
with mild severity (PHQ-9 score 10–14); (3) major de-
pression with moderate severity (PHQ-9 score 15–19);
or (4) major depression with severe severity (PHQ-9
score 20 or greater) (see Fig. 1). For this study, and as
part of the synthesis and support systems of the ISF
framework, we embedded a computer decision support
system into the STOP portal in order to guide all HCPs
with delivering a mood management intervention to
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patients. The intervention included a tailored brief inter-
vention, based on the patient’s level of depression sever-
ity and Canadian Network for Mood and Anxiety
Treatments guidelines [43], and a self-help educational
resource on mood management and smoking cessation
(Additional file 3). The latter was adapted from the work
of Munoz and colleagues [44]. The computerised alerts
and online enrollment surveys were the same for
patients in either intervention arm.
Treatment arms
The lead STOP programme implementer at each FHT
allocated to group A received personalised phone and
email-based support from the rKB, in order to help
HCPs build capacity and encourage implementation of
the mood management intervention. This was concep-
tualised under the support system of the ISF. Within
group B, lead STOP programme implementers at each
FHT received a generalised monthly email containing a
PDF resource with information on treating smokers with
mood disorders, which were part of the ISF synthesis
system. Topics included how to provide a brief mood
intervention, working with patients with co-morbid con-
ditions and managing suicidal ideation (see Additional
file 4 for the first generalised email we sent out). Some
FHTs operated multiple clinics; in these cases, the lead
implementer at each clinic received the intervention.
The rKB held a Master’s of Science specialising in
research and had prior experience working in an addic-
tions and mental health setting. The frequency of com-
munication between each FHT and the rKB, and the
content discussed, depended on the individual needs of
each clinic/lead implementer. For more information de-
scribing the role of the rKB implemented in this study,
please refer to our manuscript (Minian N, Ahad S,
Zawertailo L, Ravindran A, de Oliveira C, Baliunas D, et
Fig. 1 STOP Portal levels of depression severity
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al.: Conceptualizing the role of a remote knowledge bro-
ker: a case study in primary care settings, in
preparation).
Outcomes
The study had three outcomes. The primary outcome
was acceptance of the mood management resource by
eligible patients. This dichotomous outcome was col-
lected via the STOP online portal and measured as posi-
tive if the HCP responded “Patient accepted the
resource” to the question “Did the patient accept or de-
cline the mood resource?” If the HCP indicated that the
“Patient declined the resource” or the HCP responded
“No” to the automated prompt, “Please provide this pa-
tient with a resource on mood management”, the pri-
mary outcome was negative, and interpreted as “patient
did not accept a mood management resource”. In 18
cases (n = 8 in group A and n = 10 in group B), either
the online portal failed to activate the mood intervention
pathway despite the patient being eligible for a mood re-
source or the system failed to record the HCPs’ response
to the mood management resource provision or patient
acceptance questions. In those cases, the primary out-
come was coded as negative.
The secondary outcome was patient smoking abstinence
at 6-month follow-up. Six months after enrollment into the
STOP programme, patients were asked to complete a
follow-up survey regarding their smoking status, which was
administered via phone by trained study staff, via email
using a survey link, or by HCPs during a visit to the FHT.
Patients had one month from their 6-month enrollment an-
niversary before the survey expired. Abstinence from smok-
ing was defined as a negative response to the seven-day
point prevalence question, “Have you had a cigarette, even
a puff, in the last 7 days?” Using a seven-day window to cal-
culate point prevalence abstinence from smoking is the
most common time frame researchers’ use [45]. In addition,
the validity of self-reported abstinence from smoking has
been shown to be a good estimate of smoking status [46].
The tertiary outcome was the costs of delivering each
intervention arm, which, together with the effectiveness
outcomes, were used to undertake an economic evaluation.
In turn, the objective of the economic evaluation was to
undertake a comparative assessment of the associated costs
and benefits related to delivering each intervention arm (i.e.
the tailored rKB arm and the generic email arm).
Sample size
Previous STOP programme enrollment was used to
predict eligible FHTs and expected clinic enrollment to
perform randomisation allocation. The study was pow-
ered to detect an absolute risk difference of 0.06 with
alpha = 0.05 and power = 0.80. Sample size calculations
took into account the intra-cluster correlation (ICC)
within FHT clinics and variation in FHT sizes [47]. Pre-
vious work with HCPs being prompted to deliver a self-
help resource using the STOP portal provided an ex-
pected ICC of ρ = 0.032, an average annual enrollment
of 24 patients per clinic, and cluster size coefficient of
variation (CV) of 1.24 [48]. This yielded a sample size es-
timate of 2448 patients (1224 per arm).
Statistical analysis
Descriptive statistics were generated for patient and
FHT clinic level characteristics for each of the two treat-
ment arms. Patient characteristics were measured at en-
rollment, while FHT level characteristics were obtained
from STOP programme administrative data. Generalised
estimating equations (GEE) using a population-averaged
method, with an exchangeable correlation matrix and
robust standard errors, were used to examine the associ-
ation between treatment groups on the primary and
secondary outcomes and to account for clustering. The
study design stratification variables (organisational readi-
ness and size) were included as covariates in the model.
Other covariates were: age, gender, employment status,
education level, household income, smoking status,
willingness to quit smoking in the next 30 days, self-
reported First Nations, Inuit or Métis (FNIM) status,
past year alcohol use, past 30-day marijuana use, past
30-day opioid use, total PHQ score (the sum of com-
pleted items) and self-reported lifetime history of de-
pression, anxiety, schizophrenia, bipolar disorder,
substance use disorder, alcohol use disorder and prob-
lem gambling. The same set of covariates was used for
both the primary and secondary outcome models. All
covariates are measures of constructs specified in the
study protocol, with the exceptions of problem gambling
and FNIM status. Problem gambling was added in order
to more completely capture psychiatric morbidity, and
FNIM status because of the unique health challenges
faced by this population [49].
The study protocol specified a sensitivity analysis to de-
termine whether multiple imputation should be performed.
However, due to the amount of missing data for some base-
line covariates (Table 1), multiple imputation was used,
without a previous sensitivity analysis, for both models [50].
The missingness models included all the variables
from the main analyses, as well as the number of clinical
visits within the first 6 months of enrollment, the total
amount of NRT supplied at these visits (in weeks), aver-
age cigarettes smoked per day at baseline, time to first
cigarette after waking (within 5 min, 6–30 min, 31–60
min, more than 60 min), number of past lifetime quit at-
tempts (0, 1–5, 6–10, 11+) and smoking status at other
programme follow-ups and clinical assessments not in-
cluded in the present study (follow-ups at 3 months and
12 months post-enrollment, and whether abstinence was
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Table 1 Baseline patient and FHT characteristics for main analytic sample (n = 2763)
Group A (knowledge broker) Group B (monthly emails) Total missing
Patient level n = 1486 n = 1277 n (%)
Age in years (mean, SD) 51.1 (13.5) 50.4 (13.7) 0 (0)
Male 580 (39) 473 (37) 0 (0)
First Nations, Inuit or Métis 70 (5) 116 (9) 50 (2)
Graduated high school 722 (50) 564 (49) 161 (6)
Currently employed 533 (36) 483 (38) 28 (1)
Household income above 40k 309 (37) 277 (40) 1220 (44)
Daily smoker 1398 (94) 1191 (93) 1 (0)
Willing to set a quit date in next 30 days 1073 (84) 851 (80) 421 (15)
PHQ9 (mean, SD) 4.9 (7.0) 4.2 (6.7) 0 (0)
Consumed alcohol in past year 976 (66) 823 (65) 27 (1)
Marijuana use in past 30 days 520 (35) 443 (35) 27 (1)
Opioid use in past 30 days 376 (26) 305 (24) 31 (1)
Lifetime history of depressiona 1396 (94) 1205 (95) 11 (0)
Lifetime history of anxietya 1038 (71) 873 (69) 35 (1)
Lifetime history of schizophreniaa 47 (3) 35 (3) 44 (2)
Lifetime history of bipolar disordera 140 (10) 99 (8) 52 (2)
Lifetime history of substance use disordera 187 (13) 112 (9) 48 (2)
Lifetime history of alcohol use disordera 192 (13) 138 (11) 45 (2)
Lifetime history of problem gamblinga 36 (2) 26 (2) 43 (2)
Cluster (FHT) level (n = 58) (n = 53)
Patient Participants per cluster (mean, sd) 25.6 (36.9) 24.1 (18.2)
Year clinic enrolled first patient in the STOP programme
2011 36 (62) 29 (55)
2012 11 (19) 10 (19)
2013 4 (7) 3 (6)
2014 5 (9) 3 (6)
2015 2 (3) 5 (9)
2016 0 (0) 3 (6)
2017 0 (0) 0 (0)
2018 0 (0) 0 (0)
Local Health Integration Networksb (health regions in Ontario)
Central 2 (3) 5 (9)
Central East 5 (9) 3 (6)
Central West 2 (3) 1 (2)
Champlain 6 (10) 5 (9)
Erie-St.Clair 6 (10) 4 (8)
Hamilton Niagara Haldimand Brant 3 (5) 5 (9)
Mississauga Halton 3 (5) 0 (0)
North East 6 (10) 10 (19)
North Simcoe Muskoka 1 (2) 3 (6)
North West 4 (7) 5 (9)
South East 7 (12) 3 (6)
South West 7 (12) 3 (6)
Toronto Central 1 (2) 3 (6)
Waterloo Wellington 5 (9) 3 (6)
Values are numbers (percentages of non-missing) unless stated otherwise. SD = standard deviation
aSelf-reported lifetime history of past diagnosis
bLocal Health Integration Networks (LHINs) are agencies established by the Government of Ontario to plan, coordinate, integrate and fund health services at a local level.
They represent health regions across the province. A total of fourteen LHINs have been established across Ontario
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recorded at any clinical visit). A single missing value for
the smoking status variable was also set to “daily” (the
value in 94% of cases) to ensure convergence of some
missingness models. Using Stata 16’s MI procedures, 20
imputed datasets were generated, the substantive models
were fit using each and results combined using Rubin’s
rules. All analyses were conducted using Stata v14 and
v16 [51].
Economic evaluation
A comparative assessment of the associated costs and
benefits (as defined by outcomes 1 and 2) related to de-
livering each arm of the intervention was conducted via
an economic evaluation from the perspective of the pub-
lic third party payer (i.e. the Ontario healthcare system),
in line with the guidelines of the Canadian Agency for
Drugs and Technologies in Health [52]. We accounted
for all relevant costs associated with delivering each arm
of the trial. Intervention costs included the costs of de-
veloping, maintaining and running each arm, costs of
personnel and training and costs of supplies and ser-
vices, among other things. We used the average hourly
wage rate (including benefits) for each staff member in-
volved to obtain the cost of their time allocated to the
intervention. Other costs, such as costs of supplies and
services related to the delivery of the intervention (tele-
communications, printing, etc.), were obtained from in-
stitutional expense records. All costs were expressed in
2018 Canadian dollars.
Ethics approval
This study was approved by the Research Ethics Board
at the Centre for Addiction and Mental Health (protocol




The readiness survey was shared with all FHTs who
were actively participating in the STOP programme and
had a lead implementer in place at the time the survey
was sent out (n = 125). Eighty-four FHTs completed the
readiness survey (67% response rate). Results showed
that 68% of providers were motivated to implement a
mood management intervention as part of smoking ces-
sation programming in their FHT clinic (score of 5 or
higher; mean 5.38, SD 1.81); 63% reported their organ-
isation had the general capacity to implement a mood
management intervention (mean 5.28, SD 1.67); but only
31% believed that their organisation had the specific cap-
acity to do so (mean 3.85; SD 1.96).
FHTs were grouped into two categories: most ready
(high readiness; n = 44), and least ready (low readiness;
n = 40). Given that responding to the readiness survey
was not an eligibility criteria for participation in the trial,
FHTs who were eligible to participate in this trial but
did not answer the questionnaire (n = 39) were classified
together in a group labeled “unknown readiness”.
Intervention
At the time of randomisation, 153 FHTs were participat-
ing in the STOP programme and assessed for eligibility
(28 of these FHTS had not been shared the readiness
survey since they did not have an active STOP imple-
menter at the time or joined the STOP programme after
the survey was sent out). These clinics had enrolled at
least one patient, in English, with valid consent, during
the pre-study period. Additional eligibility criteria were
applied to this sample, including the clinic being oper-
ational at the time of randomisation, and using the
STOP portal during the pre-study period and enrolling
at least one patient with depressive symptoms. This re-
sulted in 123 FHTs being randomised into the trial.
Sixty-two FHTs were randomised to group A (rKB) and
61 FHTs were randomised to group B (generalised
emails). Fifty-eight FHTs from group A and 53 FHTs
from group B enrolled at least one eligible patient into
the study. Figure 2 shows our CONSORT flow diagram,
including the number of FHTs enrolled, allocated to
each intervention and included in our primary and sec-
ondary data analyses. Table 1 shows the number and
types of practices who were enrolled, allocated and ana-
lysed in the study. The study sample included 2763 eli-
gible patients; n = 1486 from group A and n = 1277
from group B. The observed ICC was ρ = 0.14, and the
average enrollment was 25 patients per clinic across 111
FHTs.
There were minor differences in self-identification as
First Nations, Inuit or Métis, high school completion,
willingness to set a quit date in the next 30 days, and
lifetime history of substance use disorder. There were
few notable differences between FHTs, with the excep-
tion of FHTs in group A having started implementing
the STOP programme slightly earlier and having less
representation from the northern areas of Ontario. The
FHT characteristic and the patient demographics, sepa-
rated by treatment group, are presented in Table 1.
Between February 2018 and January 2019, 7175 pa-
tients were screened for depression and 2765 (39%) re-
ported current and/or past depression. The primary
outcome is presented in Table 2. Overall, 29% (437/
1486) and 27% (345/1277) of patients accepted the mood
management resource in group A and group B, respect-
ively. The adjusted GEE showed that there was no sig-
nificant difference between the two treatment groups in
the odds of eligible patients receiving the mood manage-
ment resource.
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Fig. 2 CONSORT flow diagram
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The secondary outcome is also presented in Table 2.
The rate of response to the 6-month follow-up survey
was 77% (2136/2763 eligible patients completed the
survey between August 2018 and August 2019). The
remaining participants did not respond to repeated
contact attempts by email and phone. The response rate
was similar in both groups (group A, 1160/1486, 78.1%;
group B, 972/1277, 76.1%; χ2 = 1.48, p=0.22). The crude
quit rate from smoking cigarettes at follow-up was
29.7% (345/1160 patients) in group A and 28.5% (279/
976 patients) in group B. Twenty-three percent of pa-
tients did not complete the 6-month follow-up survey
and were therefore missing the secondary outcome.
After MI, these proportions were 27.8% (95% CI = 25.4–
30.2%) in group A and 27.5% (95% CI = 24.8–30.3%) in
group B. The adjusted GEE showed that there was no
significant difference between the treatment groups in
the patients’ odds of smoking abstinence at follow-up.
Finally, the tertiary outcome, which was used in the
economic evaluation, is presented in Table 3. Given that
there was no difference in outcomes between arms,
undertaking a cost-effectiveness analysis was no longer
feasible. Instead, we conducted a cost-minimisation
analysis, which compares the costs between two inter-
ventions with equivalent outcomes. The costs of deliver-
ing the tailored rKB (group A) and the generalised email
(group B) arms were categorised into costs, which were
specific to each arm and those common to both arms.
The costs of delivering the tailored rKB included train-
ing the rKB, preparing study instruments, communicat-
ing with HCPs of each clinic and preparing FHT-specific
data to share with HCPs ($11,839.81), while the costs of
delivering the generalised emails included costs with the
preparation of resources, communicating with FHTs and
training research staff and students ($10,611.17). Costs
common to both arms ($25,744.25) included costs asso-
ciated with meetings with co-investigators and vendors
to discuss the study design and implementation; devel-
oping study instruments for data collection, analysis and
evaluation of outcomes; preparing screening tools and
treatment guidelines associated with delivering mood in-
terventions; disseminating an online webinar to FHTs to
increase their capacity in delivering the intervention;
communications to funders, stakeholders and study
participants; and developing and analysing a readiness
survey distributed to FHTs before and after the initiative
to assess the organisational readiness to implement the
mood intervention in practice. Overall, our analysis
suggests that the generalised email arm is the cost-
minimizing arm, costing $1228.65 less than the tailored
rKB arm (Table 3).
For the cost-minimisation analysis, we conducted a
sensitivity analysis that included the costs we encoun-
tered in the study that are not necessarily required to
implement the intervention, but that may be under-
taken if additional work is required to tailor the inter-
vention in other settings or jurisdictions. Specifically,
in this sensitivity analysis, we included the costs asso-
ciated with:
1. The development of the study’s protocol which
required undertaking literature reviews to
determine the best available evidence in the field
and conducting a readiness survey to assess FHTs’
readiness to adopt a mood management
intervention as part of the STOP programme.
2. The development of a suicide risk assessment
protocol for non-clinical research staff, which was
implemented 6 months after the initiation of the
trial to examine long-term changes in depression
severity (measured via PHQ-9 score) among pa-
tients enrolled in the STOP programme. Thus, we
also included the cost associated with undertaking
literature reviews as well as the cost of implement-
ing the suicidal ideation protocol in a sensitivity
analysis.
Discussion
For this study, we tested a mid-range theory, where we
hypothesised that a more intense and personalised
Table 2 Adjusted odds ratio and 95% confidence intervals for the primary and secondary outcomes
Outcomesa No. (%) in group A
(knowledge broker)









Primary: Patient accepted the mood
resource at enrollment (n = 2763)
437/1486 (29) 345/1277 (27) 0.141 0.93 (0.60, 1.43) 0.73
Secondary: Patient quit smoking at 6-
month follow-up (n = 2136)
345/1160 (30) 279/976 (29) 0.010 1.11 (0.91, 1.35) 0.32
aThe primary outcome was derived from healthcare providers’ response to the online STOP portal prompt at patient enrollment. The secondary outcome was
measured at patients’ 6-month follow-up. The secondary outcome model was limited to patients who responded to the 6-month outcome survey
bBased on unadjusted models
cBoth models were adjusted for study stratification variables (organisational readiness and size) and the following patient-level variables measured at enrollment:
age; gender; self-reported First Nations, Inuit or Métis status; employment status; education level; household income; smoking status; willingness to quit smoking
in the next 30 days; past year alcohol use; past 30-day marijuana use; past 30-day opioid use; sum PHQ-9 score and self-reported lifetime history of depression,
anxiety, schizophrenia, bipolar disorder, substance use disorder, alcohol use disorder and problem gambling
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intervention (rKB) would be more effective at enabling
HCPs to provide their patients with mood management
resources when needed, and ultimately help more
smokers quit smoking, compared with a more passive
intervention (generic monthly emails). The results of this
adequately powered study show that our mid-range the-
ory was not supported; we failed to detect a statistically
significant difference between a personalised rKB and a
generic email-based intervention at facilitating the deliv-
ery of a mood management intervention into an existing
smoking cessation programme within primary care set-
tings (namely FHTs). The results of this trial also failed
to detect a significant difference between a personalised
rKB and a generic email-based intervention on patient
smoking cessation at 6-month follow-up. The cost mini-
misation analysis showed that an email intervention is
less costly of these two KT strategies. These results need
to be understood within the context in which they took
place. Prior to implementing the mood management
intervention, the STOP programme already had a strong
infrastructure that incorporated many virtual KT com-
ponents, including online continuing education courses
available through the Training Enhancement in Applied
Counselling and Health Project [36], an active Listserv,
and a CoP with bimonthly meetings for HCPs to learn
and exchange new information related to tobacco addic-
tion treatment. These strategies are well known to im-
prove knowledge and clinical practice behaviours [53] as
they allow HCPs to mutually engage in processes such
as de-centralised decision-making and thinking together
[54]. In addition to the existing KT infrastructure, for
this trial, we also offered two webinars to train HCPs
and embedded a computer decision support system to
guide all HCPs with delivering a mood management
intervention to patients with current and past mood
disorders. Although the rKB offered both knowledge
and tailored support beyond that of a CoP, it is
possible that the existing KT resources available to
STOP implementers, including the integration of a
decision support system, were already providing some
of the benefits of a KB. Thus the addition of the rKB
may have led to an oversaturation of information for
HCPs [55], hence revealing no statistically significant
difference. Therefore, in settings where there is a
strong KT infrastructure the added cost of a rKB
might not be justified. In this study, less than 30% of
patients who could benefit from a mood management
intervention received it, highlighting the need for ef-
fective implementation strategies and a theoretical un-
derstanding of how to increase the adoption of a
mood management intervention. Given that our pre-
implementation results, which were based on Scaccia
et al.’s R = MC2 theory [56], showed that most HCPs were
motivated to implement a mood management interven-
tion but needed help with specific capacity, we might want
to explore cognitive theories that can influence the adop-
tion of EBPs. One psychological theory that could be ex-
plored further is the parallel dual processing models of
reasoning [57, 58] which suggests that two cognitive
modes of information processing are in constant oper-
ation as humans reason; one is a fast, experiential mode
and the other one is a rational conscious mode [57, 58].
The rKB and emails may have influenced the more ra-
tional, conscious mode, but offered little for the experien-
tial mode. Finding implementation strategies that
influence both might be an important way to facilitate the
uptake of evidence into practice.
Our results differ from previous studies, which found
that KBs were effective at enhancing HCP capacity [59]
and improving practice change, compared with the pas-
sive dissemination of hardcopy and electronic instruc-
tions [60], and were also successful in facilitating the
implementation of EBPs [61]. However, these studies
were based on face-to-face meetings with stakeholders








arm total (A) + (C)
Tailored rKB
arm total (B) + (C)
Difference
[(B) + (C)] − [(A) + (C)]
Intervention costsc 10,611.17 11,839.81d 25,744.25e 36,355.42 37,584.06 1228.65
Literature review and
intervention preparation costs
– – 5779.33 5779.33 5779.33 0
Suicidal ideation protocol costs – – 3953.87 3953.87 3953.87 0
Total costs 10,611.17 11,839.81 35,477.45 46,088.62 47,317.26 1228.65
aParticipants in the generic email arm received monthly messages (related to smoking and depression) exclusively via email
bParticipants in the rKB arm received personalised support through phone and email-based check-ins
cIntervention costs for the generic email arm included costs with the preparation of resources, communicating with FHTs and training research staff and students;
Intervention costs for the tailored rKB arm included training the rKB, preparing study instruments, communicating with HCPs of each clinic and preparing FHT-
specific data to share with HCPs
dThis value includes delivery-related costs (not intervention costs) of the tailored remote knowledge broker arm (11,819.81) and the cost of telecommunications
(emails, phone calls) (20.00)
eThis value includes the cost of delivering both arms (22,167.25), the cost of running two webinars (1650.00) and the cost of mailing materials to participating
Family Health Teams (1927.00)
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[59–61], rather than remote methods of communication
reported in our study. This lack of in-person meetings
may have, in part, contributed to the differences ob-
served from earlier research. Previous authors explor-
ing technology-based KT strategies in healthcare have
reported challenges, including lack of engagement and
low prioritisation by end users [18, 20, 22, 62]. It is
possible that the success of KB interventions, beyond
that of email-based interventions, require at least an
initial face-to-face interaction in order to establish a
meaningful connection and thoroughly explain the
initiative, before shifting to remote methods of
brokering [20].
Despite this notion, findings from our trial are com-
parable with results from an RCT conducted by Dobbins
et al., who found that an in-person KB was not more ef-
fective than tailored messaging, for promoting evidence-
informed decision-making in public health [63]. Similar
to the authors’ remarks, we consider that KB success
may be influenced by the prioritisation of research evi-
dence within an organisation, whereby stakeholders with
low perceived research culture and priorities may benefit
from a KB more than those with high research culture
[63]. We also consider that within the context of FHTs
delivering smoking cessation treatment, simple KT inter-
ventions may be just as effective as more complex, mul-
ticomponent KT strategies [63, 64]. Although the email
intervention (group B) was generalised across FHTs, and
less personalised than the rKB, both strategies contained
relevant and accessible information for the HCP, which
are important for facilitating practice change [63]. Given
that many clinicians working in primary care are often
faced with competing priorities and limited time, the
monthly email resources may have provided just the
right amount of digestible information, which HCPs
could review on their own time, rather than having to
dedicate time toward formal phone check-ins with the
rKB. In addition, more in-depth tools and resources
shared by the rKB may have been too rigorous for HCPs
working within an interdisciplinary environment,
whereby more intensive interventions would be offered
by mental health specialists.
The evidence we provided related to costs and out-
comes associated with mood management interventions
within smoking cessation programming demonstrates
that the generalised email arm is the cost-minimizing
arm compared with the tailored rKB arm. Given that
once email content is prepared there are no costs of
scaling it up, whereas offering support from a rKB does
incur more costs as additional clinics are included,
implementing an email-based KT intervention may be
more feasible to integrate within interdisciplinary pri-
mary care organisations. This result might inform future
policy decisions regarding the cost-effectiveness of mood
management interventions within single-payer health-
care systems.
Strengths and limitations
One of the main strengths of our trial was the pragmatic
design testing the real-world effectiveness of the rKB
intervention, and the large sample size utilised, which in-
cluded 123 FHTs across Ontario and 2763 patients.
Conducting an implementation readiness assessment
also allowed us to tailor our KT materials (webinars,
emails and rKB) to the needs of HCPs in order to in-
crease uptake in both groups. In addition, by stratifying
FHTs based on implementation readiness, we were able
to account for the differences in organisational readiness
between both groups.
A limitation to our study design was the lack of a con-
trol arm (i.e. no intervention at all), which would have
provided an additional comparison to assess the effect-
iveness of both the rKB and the general emails for pro-
viding implementation support to HCPs. However, this
was not the planned purpose of the trial and would have
required a larger sample size. In addition, given the evi-
dence supporting the integration of mood interventions
within smoking cessation programming [25], and results
from our readiness survey, where only 31% of HCPs re-
ported having the specific capacity to implement mood
management treatment, we felt it was important to pro-
vide all FHTs with some form of intervention support,
varying in intensity, rather than no intervention at all.
Finally, few programmes would introduce an automated
treatment pathway with no support or training whatso-
ever, and including this as the control condition might
therefore provide a somewhat artificial comparison.
A second limitation was that our primary outcome
measure did not provide a full picture of how the rKB
versus the generalised emails may have impacted HCP
decision-making over the intervention period. For in-
stance, the rKB may have improved HCPs’ knowledge
and skills in delivering mood interventions within smok-
ing cessation treatment and influenced the implementa-
tion of FHT policies related to mood management.
However, while these are important outcomes, in order
for the mood management intervention to work,
smokers with current or past depression must accept the
intervention; thus, we chose this as our primary
outcome.
Although HCPs were assigned to two different treat-
ment groups, we did not account for whether HCPs in
group A were reached by the rKB and did not ascertain
whether HCPs in group B actually read their monthly
emails. However, given that the purpose of this study
was to implement and examine mood management
interventions in a real-life pragmatic treatment
programme, our outcomes are likely more generalizable
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to real-world treatment settings where HCPs may be
busy and not necessarily responsive to the communica-
tions they receive. Our secondary outcome was also not
available for the 23% of patients who did not complete a
6-month follow-up. Another limitation is that patients
who completed their baseline enrollment on paper, or in
French, were excluded from the trial. Although there is
no reason to think that their response to the interven-
tion would have differed from those of included patients,
their removal reduces the representativeness of the final
sample. There is also the possibility of contamination of
knowledge; HCPs working in FHTs assigned to group A
might share some of the KB insights with HCPs from
group B, and similarly, HCPs from group B might for-
ward emails with HCPs working in FHTs assigned to
group A. This contamination could have potentially
compromised the effect of the trial, leading to a more
conservative reporting estimate of the study’s overall ef-
fect. To our knowledge, however, as detected during a
rKB phone call, only one HCP was exposed to both arms
of the trial, that is they were employed at both a FHT
assigned to group A and a FHT assigned to group B.
Further, the occurrence of HCPs concurrently working
at two STOP FHTs is low, and unlikely to have an im-
pact on our results.
Conclusions
This large study contributes to the implementation sci-
ence literature by empirically testing a mid-range imple-
mentation theory (that active implementation strategies
are more effective than passive ones) and showing that
in the particular context it was tested, this theory was in-
accurate. In addition, the results of this study show that
the passive strategy is less costly to implement and sus-
tain over the long term. More research is needed to
examine in which contexts (e.g. sites without an existing
KT infrastructure) active implementation strategies are
more effective than passive ones. The study also pro-
vides a real-world example of how the Interactive Sys-
tems Framework for Dissemination and Implementation
can be used in practice to guide implementation.
Future research could examine if dosage, number of
interactions and /or total time spent, between the rKB
and HCPs was a contributing factor in the success of the
intervention. Patient involvement in requesting the
intervention should also be studied to increase the over-
all implementation of this evidence-based practice in
primary care settings. Finally, future work will also
examine if HCPs continue to offer the mood interven-
tion to patients despite the cessation of the rKB and the
emails.
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